A preliminary study to evaluate the effect of intravenous ribavirin treatment on survival rates in Crimean–Congo hemorrhagic fever
- 31 October 2008
- journal article
- other
- Published by Elsevier in Journal of Infection
- Vol. 57 (4) , 350-351
- https://doi.org/10.1016/j.jinf.2008.07.007
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Crimean–Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapyJournal of Infection, 2006
- Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measuresJournal of Medical Microbiology, 2005
- Characteristics of Patients with Crimean-Congo Hemorrhagic Fever in a Recent Outbreak in Turkey and Impact of Oral Ribavirin TherapyClinical Infectious Diseases, 2004
- The Efficacy of Oral Ribavirin in the Treatment of Crimean-Congo Hemorrhagic Fever in IranClinical Infectious Diseases, 2003
- Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infectionAntiviral Research, 1993
- Inhibition of Crimean-Congo Hemorrhagic Fever Viral Infectivity Yields in Vitro by RibavirinThe American Journal of Tropical Medicine and Hygiene, 1989